ID

42958

Description

Keywords

Versions (4)
  1. 11/11/11 11/11/11 -
  2. 11/11/11 11/11/11 -
  3. 3/21/14 3/21/14 - Martin Dugas
  4. 9/17/21 9/17/21 -
Uploaded on

September 17, 2021

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Criteria NCT00044564

English

Eligibility

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion criteria
Description

Inclusion criteria

Alias
UMLS CUI
C1512693
measurable disease as defined by the presence of at least one measurable lesion
Description

Advanced Renal Cell Carcinoma

Data type

boolean

Alias
UMLS CUI-1
C0007134
prior immunotherapy (up to 2 regimens) or prior radiotherapy is permitted but at least 4 weeks must have elapsed prior to enter study
Description

Prior immunotherapy or radiotherapy

Data type

boolean

Alias
UMLS CUI-1
C0021083
UMLS CUI-2
C1522449
life expectancy of at least 12 weeks
Description

Life expectancy

Data type

boolean

Alias
UMLS CUI-1
C0023671
adequate bone marrow, liver and kidney function
Description

Bone marrow, liver, kidney

Data type

boolean

Alias
UMLS CUI-1
C0023508
UMLS CUI-2
C1287267
UMLS CUI-3
C0019046
UMLS CUI-4
C0525032
UMLS CUI-5
C0011221
UMLS CUI-6
C0010294
Exclusion criteria
Description

Exclusion criteria

Alias
UMLS CUI
C0680251
excluded medical conditions like: pre-existing neuropathy, active heart diseases or ischemia, serious infections, HIV infection, chronic hepatitis B or C, brain metastasis, seizures, hypersensitivity to taxanes, organ transplants, some previous cancers
Description

excluded medical conditions

Data type

boolean

Alias
UMLS CUI-1
C0442874
UMLS CUI-2
C0018799
UMLS CUI-3
C0009450
UMLS CUI-4
C0019693
UMLS CUI-5
C0019158
UMLS CUI-6
C0220650
UMLS CUI-7
C0036572
UMLS CUI-8
C0274302
UMLS CUI-9
C0029216
UMLS CUI-10
C0006826
excluded therapies and medications, previous and concomitant such as: anticancer chemotherapy or immunotherapy during the study or within 4 weeks prior to study entry; more than two prior anticancer chemotherapy regimens; radiotherapy during study or within 4 weeks prior to study entry; bone marrow transplant
Description

excluded therapies and medications

Data type

boolean

Alias
UMLS CUI-1
C0392920
UMLS CUI-2
C1963758
UMLS CUI-3
C1522449
UMLS CUI-4
C0005961
others: pregnant or breast-feeding patients; both men and women enrolled in this trial must use adequate barrier birth control measures during the course of the trial; substance abuse, medical, psychological or social conditions that may interfere with the patient's participation
Description

other exclusion criteria

Data type

boolean

Alias
UMLS CUI-1
C0549206
UMLS CUI-2
C0006147
UMLS CUI-3
C2919192
UMLS CUI-4
C0013146
UMLS CUI-5
C0376405
Back to the top of the page

Similar models

Eligibility

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion criteria
C1512693 (UMLS CUI)
Advanced Renal Cell Carcinoma
Item
measurable disease as defined by the presence of at least one measurable lesion
boolean
C0007134 (UMLS CUI-1)
Prior immunotherapy or radiotherapy
Item
prior immunotherapy (up to 2 regimens) or prior radiotherapy is permitted but at least 4 weeks must have elapsed prior to enter study
boolean
C0021083 (UMLS CUI-1)
C1522449 (UMLS CUI-2)
Life expectancy
Item
life expectancy of at least 12 weeks
boolean
C0023671 (UMLS CUI-1)
Bone marrow, liver, kidney
Item
adequate bone marrow, liver and kidney function
boolean
C0023508 (UMLS CUI-1)
C1287267 (UMLS CUI-2)
C0019046 (UMLS CUI-3)
C0525032 (UMLS CUI-4)
C0011221 (UMLS CUI-5)
C0010294 (UMLS CUI-6)
Item Group
Exclusion criteria
C0680251 (UMLS CUI)
excluded medical conditions
Item
excluded medical conditions like: pre-existing neuropathy, active heart diseases or ischemia, serious infections, HIV infection, chronic hepatitis B or C, brain metastasis, seizures, hypersensitivity to taxanes, organ transplants, some previous cancers
boolean
C0442874 (UMLS CUI-1)
C0018799 (UMLS CUI-2)
C0009450 (UMLS CUI-3)
C0019693 (UMLS CUI-4)
C0019158 (UMLS CUI-5)
C0220650 (UMLS CUI-6)
C0036572 (UMLS CUI-7)
C0274302 (UMLS CUI-8)
C0029216 (UMLS CUI-9)
C0006826 (UMLS CUI-10)
excluded therapies and medications
Item
excluded therapies and medications, previous and concomitant such as: anticancer chemotherapy or immunotherapy during the study or within 4 weeks prior to study entry; more than two prior anticancer chemotherapy regimens; radiotherapy during study or within 4 weeks prior to study entry; bone marrow transplant
boolean
C0392920 (UMLS CUI-1)
C1963758 (UMLS CUI-2)
C1522449 (UMLS CUI-3)
C0005961 (UMLS CUI-4)
other exclusion criteria
Item
others: pregnant or breast-feeding patients; both men and women enrolled in this trial must use adequate barrier birth control measures during the course of the trial; substance abuse, medical, psychological or social conditions that may interfere with the patient's participation
boolean
C0549206 (UMLS CUI-1)
C0006147 (UMLS CUI-2)
C2919192 (UMLS CUI-3)
C0013146 (UMLS CUI-4)
C0376405 (UMLS CUI-5)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial